Q2 2014 Holdings
Filed 2014-08-14 | 120 holdings | $19.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Xencor Inc(XNCR) | COM | 98401F105 | $20.2K | 1,740,621 | 0.1% |
| Walgreen Co | COM | 931422109 | $20.9K | 282,000 | 0.1% |
| Shire PLC | SPONSORED ADR | 82481R106 | $21.2K | 90,000 | 0.1% |
| Zimmer Hldgs Inc(ZBH) | COM | 98956P102 | $25.2K | 242,500 | 0.1% |
| Dyax Corp | COM | 26746E103 | $26.0K | 2,710,598 | 0.1% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $36.0K | 1,800,000 | 0.2% |
| Questcor Pharmaceuticals Inc | COM | 74835Y101 | $37.0K | 400,000 | 0.2% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $41.2K | 12,339,444 | 0.2% |
| Taro Pharmaceutical Inds LTD | SHS | M8737E108 | $42.3K | 301,333 | 0.2% |
| Celgene Corp(CELG) | COM | 151020104 | $43.6K | 507,488 | 0.2% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $44.5K | 470,142 | 0.2% |
| Acelrx Pharmaceuticals Inc(ACRXUSD) | COM | 00444T100 | $67.4K | 6,574,060 | 0.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $68.3K | 4,599,867 | 0.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $76.2K | 2,558,478 | 0.4% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $100.0K | 1,860 | 0.5% |
| Catalyst Pharm Partners Inc(CPRX) | COM | 14888U101 | $3.8M | 1,500,000 | 19.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $14.8M | 653,000 | 75.1% |